Guiheen Lawrence P.'s Form 4 filing
Adma Biologics, Inc. (ADMA) · filed May 23, 2025
- Accession no.
- 0001140361-25-020376
- Filed
- May 23, 2025
- Trade date
- May 21-22, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $182.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guiheen Lawrence P.CIK 0001554353 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Common Stock | MOption exerciseAcquired | +7,779 | $5.96 | +$46,362.84 | 122,609 | Direct | |
| May 21, 2025 | Common Stock | SSaleDisposed | −7,779 | $20.32 | −$158,069.28 | 114,830 | Direct | |
| May 22, 2025 | Common Stock | MOption exerciseAcquired | +1,221 | $5.96 | +$7,277.16 | 116,051 | Direct | |
| May 22, 2025 | Common Stock | SSaleDisposed | −1,221 | $20.12 | −$24,566.52 | 114,830 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 21, 2025 | Common Stock | MOption exerciseDisposed | −7,779 | $0.00 | $0 | 1,221 | Direct | |
| May 22, 2025 | Common Stock | MOption exerciseDisposed | −1,221 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.